335 related articles for article (PubMed ID: 25239128)
21. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
[TBL] [Abstract][Full Text] [Related]
22. Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review.
Palacios-Ceña D; Losa-Iglesias ME; Alvarez-López C; Cachón-Pérez M; Reyes RA; Salvadores-Fuentes P; Fernández-de-Las-Peñas C
J Adv Nurs; 2011 Dec; 67(12):2537-50. PubMed ID: 21615459
[TBL] [Abstract][Full Text] [Related]
23. Patient and Professional Factors That Impact the Perceived Likelihood and Confidence of Healthcare Professionals to Discuss Implantable Cardioverter Defibrillator Deactivation in Advanced Heart Failure: Results From an International Factorial Survey.
Hill L; McIlfatrick S; Taylor BJ; Jaarsma T; Moser D; Slater P; McAloon T; Dixon L; Donnelly P; Stromberg A; Fitzsimons D
J Cardiovasc Nurs; 2018; 33(6):527-535. PubMed ID: 29727378
[TBL] [Abstract][Full Text] [Related]
24. "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators.
Goldstein NE; Mehta D; Siddiqui S; Teitelbaum E; Zeidman J; Singson M; Pe E; Bradley EH; Morrison RS
J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):7-12. PubMed ID: 18095037
[TBL] [Abstract][Full Text] [Related]
25. The effects of age on quality of life in implantable cardioverter defibrillator recipients.
Hamilton GA; Carroll DL
J Clin Nurs; 2004 Feb; 13(2):194-200. PubMed ID: 14723671
[TBL] [Abstract][Full Text] [Related]
26. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
[TBL] [Abstract][Full Text] [Related]
27. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
Waterhouse E; Ahmad F
Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
[TBL] [Abstract][Full Text] [Related]
28. Factors influencing health-related quality of life in patients with an implantable cardioverter defibrillator: A systematic review.
Wong F; Sit J; Wong E
JBI Libr Syst Rev; 2012; 10(43):2785-2881. PubMed ID: 27820203
[TBL] [Abstract][Full Text] [Related]
29. 'You can't start a car when there's no petrol left': a qualitative study of patient, family and clinician perspectives on implantable cardioverter defibrillator deactivation.
Standing H; Thomson RG; Flynn D; Hughes J; Joyce K; Lobban T; Lord S; Matlock DD; McComb JM; Paes P; Wilkinson C; Exley C
BMJ Open; 2021 Jul; 11(7):e048024. PubMed ID: 34230020
[TBL] [Abstract][Full Text] [Related]
30. Exploring the patients' experiences of living with a subcutaneous implantable cardioverter defibrillator.
Forman J; Baumbusch J; Jackson H; Lindenberg J; Shook A; Bashir J
Eur J Cardiovasc Nurs; 2018 Dec; 17(8):698-706. PubMed ID: 29775072
[TBL] [Abstract][Full Text] [Related]
31. Deactivation of implantable cardioverter-defibrillators at end of life.
Pettit SJ; Jackson CE; Gardner RS
Future Cardiol; 2013 Nov; 9(6):885-96. PubMed ID: 24180544
[TBL] [Abstract][Full Text] [Related]
32. Information provision and follow-up of French patients with implantable cardioverter-defibrillators: The APODEC survey.
Halin A; Hamelin JL; Defaye P; Deharo JC; Fauchier L; Marijon E; Piot O; Boveda S
Arch Cardiovasc Dis; 2023 Dec; 116(12):572-579. PubMed ID: 37953189
[TBL] [Abstract][Full Text] [Related]
33. Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; Theuns DA; Bhagwandien RE; van Bruchem-Visser RL; Lokker IE; van der Heide A; Rietjens JA
Eur J Cardiovasc Nurs; 2019 Aug; 18(6):449-457. PubMed ID: 30995145
[TBL] [Abstract][Full Text] [Related]
34. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
Herman D; Stros P; Curila K; Kebza V; Osmancik P
Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
[TBL] [Abstract][Full Text] [Related]
35. Improving guideline-mandated care of patients with implantable cardiac defibrillators.
Garner D; Blackburn M; Wright DJ; Rao A
Br J Hosp Med (Lond); 2020 Aug; 81(8):1-10. PubMed ID: 32845764
[TBL] [Abstract][Full Text] [Related]
36. Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks?
Thylén I; Moser DK; Chung ML; Miller J; Fluur C; Strömberg A
Int J Cardiol Heart Vessel; 2013 Dec; 1():22-31. PubMed ID: 29450154
[TBL] [Abstract][Full Text] [Related]
37. Experiences of adults living with an implantable cardioverter defibrillator for cardiovascular disease: a systematic review of qualitative evidence.
Pike A; Dobbin-Williams K; Swab M
JBI Evid Synth; 2020 Nov; 18(11):2231-2301. PubMed ID: 32813405
[TBL] [Abstract][Full Text] [Related]
38. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator.
Sherazi S; Daubert JP; Block RC; Jeevanantham V; Abdel-Gadir K; DiSalle MR; Haley JM; Shah AH
Mayo Clin Proc; 2008 Oct; 83(10):1139-41. PubMed ID: 18828973
[TBL] [Abstract][Full Text] [Related]
39. Management of patients with ICDs at the end of life (EOL): a qualitative study.
Kelley AS; Mehta SS; Reid MC
Am J Hosp Palliat Care; 2008 Dec-2009 Jan; 25(6):440-6. PubMed ID: 18812618
[TBL] [Abstract][Full Text] [Related]
40. Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly.
Wright GA; Klein GJ; Gula LJ
Curr Opin Cardiol; 2013 Jan; 28(1):43-9. PubMed ID: 23128499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
